Literature DB >> 9583858

Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells.

P Schemmer1, R Schoonhoven, J A Swenberg, H Bunzendahl, R G Thurman.   

Abstract

BACKGROUND: The etiology of primary graft nonfunction and dysfunction is unknown but most likely involves Kupffer cell-dependent reperfusion injury. However, the donor operation and surgical technique may also have an effect on the outcome after transplantation. Because liver manipulation during harvest cannot be prevented completely with standard procedures, its effect on survival was assessed here.
METHODS: Donor livers were harvested from female Sprague-Dawley rats (200-230 g). Briefly, after minimal dissection during the first 12 min, livers were either manipulated gently or left alone for 13 subsequent minutes. At 25 min, all livers were perfused with cold University of Wisconsin solution via the portal vein, and transplantation was performed after cold storage (1 hr). In some rats, Kupffer cells were destroyed with gadolinium chloride or inactivated with dietary glycine before harvest. Survival, proteolytic activity in the rinse effluent, serum transaminases, trypan blue distribution to index microcirculation, and histology were compared.
RESULTS: In the nonmanipulated group, survival was 100% after transplantation; however, gentle manipulation decreased survival by 70%. Further, manipulation elevated transaminases fivefold and caused about 200% necrosis. At harvest, proteolytic activity and the time for trypan blue to distribute homogeneously were elevated three- to eightfold by manipulation. Gadolinium chloride and glycine prevented the effects of manipulation on all parameters studied.
CONCLUSION: These data indicate for the first time that brief, gentle manipulation of the donor liver has a marked detrimental effect on survival by priming or activating Kupffer cells. This may represent an important early event in pathogenesis, because Kupffer cells play an important role in primary graft nonfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583858     DOI: 10.1097/00007890-199804270-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury.

Authors:  Mohammed Reza Moussavian; Claudia Scheuer; Michael Schmidt; Otto Kollmar; Matthias Wagner; Maximilian von Heesen; Martin K Schilling; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

Review 2.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Anti-inflammatory role of glycine in reducing rodent postoperative inflammatory ileus.

Authors:  B Stoffels; A Türler; J Schmidt; A Nazir; T Tsukamoto; B A Moore; C Schnurr; J C Kalff; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-10-01       Impact factor: 3.598

4.  Thoracic epidural anesthesia reverses sepsis-induced hepatic hyperperfusion and reduces leukocyte adhesion in septic rats.

Authors:  Hendrik Freise; Fritz Daudel; Christina Grosserichter; Stefan Lauer; Juergen Hinkelmann; Hugo K Van Aken; Andreas W Sielenkaemper; Martin Westphal; Lars G Fischer
Journal:  Crit Care       Date:  2009-07-13       Impact factor: 9.097

5.  HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation.

Authors:  Qinlong Liu; Helge Bruns; Daniel Schultze; Yi Xue; Markus Zorn; Christa Flechtenmacher; Beate K Straub; Ursula Rauen; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2012-11-01       Impact factor: 3.445

6.  Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology.

Authors:  Kilian Weigand; Sylvia Brost; Niels Steinebrunner; Markus Büchler; Peter Schemmer; Martina Müller
Journal:  HPB Surg       Date:  2012-05-30

Review 7.  Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.

Authors:  Judith Kahn; Peter Schemmer
Journal:  Visc Med       Date:  2018-10-30

8.  Effects of a preconditioning oral nutritional supplement on pig livers after warm ischemia.

Authors:  Arash Nickkholgh; Zhanqing Li; Xue Yi; Elvira Mohr; Rui Liang; Saulius Mikalauskas; Marie-Luise Gross; Markus Zorn; Steffen Benzing; Heinz Schneider; Markus W Büchler; Peter Schemmer
Journal:  HPB Surg       Date:  2012-06-25

9.  HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

Authors:  Steffen P Luntz; Kristina Unnebrink; Monika Seibert-Grafe; Hartwig Bunzendahl; Thomas W Kraus; Markus W Büchler; Ernst Klar; Peter Schemmer
Journal:  BMC Surg       Date:  2005-08-17       Impact factor: 2.102

Review 10.  A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation.

Authors:  Kenya Yamanaka; Philipp Houben; Helge Bruns; Daniel Schultze; Etsuro Hatano; Peter Schemmer
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.